The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Niva Thyroid
thyroid, porcine · THYROID 240 mg/1 · Tablet · Oral · Nivagen Pharmaceuticals, Inc.
NDC 75834-0316-01 · 100 TABLET in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for thyroid, porcine (oral solid) in the next 90 days
sole-source market · price up 5% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of thyroid, porcine (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | THYROID 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| A-S Medication Solutions | THYROID 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| A-S Medication Solutions | THYROID 90 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Allergan, Inc. | SUS SCROFA THYROID 240 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Allergan, Inc. | SUS SCROFA THYROID 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Allergan, Inc. | SUS SCROFA THYROID 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Allergan, Inc. | SUS SCROFA THYROID 180 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Allergan, Inc. | SUS SCROFA THYROID 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Allergan, Inc. | SUS SCROFA THYROID 90 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Allergan, Inc. | SUS SCROFA THYROID 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | SUS SCROFA THYROID 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | THYROID 90 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Nivagen Pharmaceuticals, Inc. | THYROID 90 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Nivagen Pharmaceuticals, Inc. | THYROID 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Nivagen Pharmaceuticals, Inc. | THYROID 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Nivagen Pharmaceuticals, Inc. | THYROID 180 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Nivagen Pharmaceuticals, Inc. | THYROID 240 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Nivagen Pharmaceuticals, Inc. | THYROID 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Nivagen Pharmaceuticals, Inc. | THYROID 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Nivagen Pharmaceuticals, Inc. | THYROID 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Allergan, Inc. | SUS SCROFA THYROID 15 mg/1 | Jul 15, 2026 | Sep 1, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Niva Thyroid — NDC 75834-0316-01," retrieved September 3, 2026, https://drugdashboards.com/drug/75834031601.
Free to cite with attribution — see how the data is put together.